MONOCLONAL ANTIBODY
MONOCLONAL ANTIBODY
批准号:
8243713
负责人:
LISA K. DENZIN
金额:
$31.49万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Affinity ChromatographyAntigensBiomedical ResearchCancer Center Support GrantCell SeparationCellsCore FacilityDiseaseEnzymesFlow CytometryGenerationsGoalsHybridomasImmunoelectron MicroscopyImmunofluorescence ImmunologicImmunoprecipitationIn VitroInfectionMalignant NeoplasmsMemorial Sloan-Kettering Cancer CenterModificationMonoclonal AntibodiesMycoplasmaPopulationProductionProteinsRecombinantsResearchResearch PersonnelResearch SupportSamplingServicesSourceT-Cell ActivationTechniquesTestingWestern Blottingcell bankcellular imagingcostcytochemistrydisease diagnosisin vivointerestmilligramprogramsresearch studytissue culturetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Monoclonal Antibody Core Facility (MACF) provides the following four high quality services not only
at a reasonable cost to investigators but also in a timely manner.
1. The generation of new MAbs / hybridomas to a specific antigen of interest.
2. MAb production (in vitro), purification and modification (including conjugation to fluorphores,
biotion and enzymes and the fragmentation of MAbs).
3. Mycoplasma testing of tissue culture samples.
4. In vitro production of recombinant/secreted proteins.
Monoclonal antibodies (MAbs) are essential tools used in most if not all fields of biomedical research, in the
diagnosis of diseases, and in the treatment of diseases such as infections and cancer. The goal of the
MACF is to support the research interests of MSKCC investigators by providing key services related to the
production, purification and use of MAbs.
Over the last 5 years demand for the MACF services has remained consistently high. From July 2005
through July 2006, 61 investigators from 9 out of 10 programs placed orders with the facility for any
combination of the services noted above.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Molecular Mechanisms by which the Paf Oncogene Mediates Hematopoiesis
-
批准号:8492424
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2013
-
负责人:LISA K. DENZIN
-
依托单位:
The Molecular Mechanisms by which the Paf Oncogene Mediates Hematopoiesis
-
批准号:8605171
-
项目类别:
-
资助金额:$23.85万
-
财政年份:2013
-
负责人:LISA K. DENZIN
-
依托单位:
The Molecular Mechanisms by which the Paf Oncogene Mediates Hematopoiesis
-
批准号:8701694
-
项目类别:
-
资助金额:$7.81万
-
财政年份:2013
-
负责人:LISA K. DENZIN
-
依托单位:
MONOCLONAL ANTIBODY
-
批准号:7671820
-
项目类别:
-
资助金额:$16.49万
-
财政年份:2008
-
负责人:LISA K. DENZIN
-
依托单位:
H2-O Mediated Antigen Focusing Modulates B Cell Immunity
-
批准号:6929455
-
项目类别:
-
资助金额:$41.85万
-
财政年份:2005
-
负责人:LISA K. DENZIN
-
依托单位:
H2-O Mediated Antigen Focusing Modulates B Cell Immunity
-
批准号:7558276
-
项目类别:
-
资助金额:$42.46万
-
财政年份:2005
-
负责人:LISA K. DENZIN
-
依托单位:
H2-O Mediated Antigen Focusing Modulates B Cell Immunity
-
批准号:7013578
-
项目类别:
-
资助金额:$40.87万
-
财政年份:2005
-
负责人:LISA K. DENZIN
-
依托单位:
H2-O Mediated Antigen Focusing Modulates B Cell Immunity
-
批准号:7333286
-
项目类别:
-
资助金额:$42.46万
-
财政年份:2005
-
负责人:LISA K. DENZIN
-
依托单位:
H2-O Mediated Antigen Focusing Modulates B Cell Immunity
-
批准号:7175420
-
项目类别:
-
资助金额:$43.28万
-
财政年份:2005
-
负责人:LISA K. DENZIN
-
依托单位:
MODULATION OF CLASS II ANTIGEN PROCESSING BY HLA DO
-
批准号:6163999
-
项目类别:
-
资助金额:$22.58万
-
财政年份:1999
-
负责人:LISA K. DENZIN
-
依托单位:
MODULATION OF CLASS II ANTIGEN PROCESSING BY HLA DO
-
批准号:6510912
-
项目类别:
-
资助金额:$23.95万
-
财政年份:1999
-
负责人:LISA K. DENZIN
-
依托单位:
MODULATION OF CLASS II ANTIGEN PROCESSING BY HLA DO
-
批准号:6018199
-
项目类别:
-
资助金额:$22.61万
-
财政年份:1999
-
负责人:LISA K. DENZIN
-
依托单位:
MODULATION OF CLASS II ANTIGEN PROCESSING BY HLA DO
-
批准号:6362428
-
项目类别:
-
资助金额:$23.26万
-
财政年份:1999
-
负责人:LISA K. DENZIN
-
依托单位:
MODULATION OF CLASS II ANTIGEN PROCESSING BY HLA DO
-
批准号:6632043
-
项目类别:
-
资助金额:$24.67万
-
财政年份:1999
-
负责人:LISA K. DENZIN
-
依托单位:
MONOCLONAL ANTIBODY
-
批准号:8182202
-
项目类别:
-
资助金额:$16.51万
-
财政年份:--
-
负责人:LISA K. DENZIN
-
依托单位:
MONOCLONAL ANTIBODY
-
批准号:8182223
-
项目类别:
-
资助金额:$32.5万
-
财政年份:--
-
负责人:LISA K. DENZIN
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: